Singleton,
Conditions
Interventions
Comparative Magnesium sulphate in the differnce dose : Magnesium sulphate 5 g. IV loading follow by 2 g/hr. IV continuous infusion.,Comparative Magnesium sulphate in the differnce dose : Magnesium sul
Active Comparator Drug,Active Comparator Drug
Magnesium sulphate,Magnesium sulphate
Sponsors
none
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Singleton pregnant women who diagnosed severe preeclampsia or severe preeclampsia superimposed chronic hypertension at gestational aged over 34 completed weeks. 2.The disease treated by intravenous regimen of magnesium sulphate 3.Accepted and signed the informed consent form
Exclusion criteria
Exclusion criteria: 1.Pregnant women who allegied to magnesium sulphate 2.Pregnant women who had history of chronic kidney disease or impaired renal function 3.Fatal anomaly was detected in current pregnancy 4.Pregnant women who got pregestational diabetes mellitus and gestational diabetes mellitus type A2 5.Pregnancy women who denied the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum magnesium level 4 hours after the treatment autometic mechine | — |
Secondary
| Measure | Time frame |
|---|---|
| neonatal outcomes 24 hours after delivery observation, review medical chart, umibilical cord blood magnesium levels,maternal outcomes begin at treatment to 24 hours after delivery observation, review medical chart | — |
Countries
Thailand
Contacts
Public ContactSanpon Diawtipsukon
Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol Universi
Outcome results
None listed